Press Releases AllCelleron TherapeuticsEvents & PresentationsPress ReleasesRelevant Publications Celleron Therapeutics announces completion of a new funding round with international investors January 31, 2017 TLR Adaptor Protein MYD88 Mediates Sensitivity to HDAC Inhibitors via a Cytokine-Dependent Mechanism December 10, 2016 ASH Dec 16 Poster 2 December 10, 2016 ASH Dec 16 Poster 1 December 10, 2016 Adjuvant capecitabine plus bevacizumab versus capecitabine alone in patients with colorectal cancer (QUASAR 2) November 10, 2016 ESMO 2016 Poster 1 May 2, 2016 Celleron Therapeutics announces encouraging clinical results with its new cancer drug CXD101 in heavily pre-treated unresponsive cancer patients December 1, 2015 Evaluation of PIK3CA Mutation As a Predictor of Benefit From Nonsteroidal Anti-Inflammatory Drug Therapy in Colorectal Cancer December 10, 2013 Tailoring treatment and trials to prognosis August 10, 2013 Use of multivariate analysis to suggest a new molecular classification of colorectal cancer February 10, 2013 Predictive biomarkers: a paradigm shift towards personalized cancer medicine October 10, 2011 « Previous 1 2 3 4
